• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性醛固酮增多症患者腺瘤切除后血浆中哇巴因样免疫反应性高水平恢复正常。

Normalization of high plasma level of ouabain-like immunoreactivity in primary aldosteronism after removal of adenoma.

作者信息

Masugi F, Ogihara T, Hasegawa T, Sakaguchi K, Kumahara Y

机构信息

Department of Medicine and Geriatrics, Osaka University Medical School, Japan.

出版信息

J Hum Hypertens. 1988 Jun;2(1):17-20.

PMID:3236314
Abstract

Plasma ouabain-like immunoreactivity, which has been supposed to be associated with hypertension, was significantly higher in five patients with primary aldosteronism than in age-matched normotensive subjects. High plasma levels of ouabain-like immunoreactivity decreased to normal after removal of adenoma. Extracts of adenoma tissue did not contain any apparent ouabain-like immunoreactivity. Anti-ouabain antibody used in this study did not cross-react with aldosterone, cortisol, corticosterone, arachidonic acid or lysophosphatidylcholine. Hypertension, hypokalemia, a high plasma aldosterone level and low plasma renin activity were also normalized after surgery. These results indicate that hyperaldosteronism induces the high plasma level of ouabain-like immunoreactivity and this is associated in part with high blood pressure (BP) in primary aldosteronism.

摘要

血浆哇巴因样免疫反应性被认为与高血压有关,5例原发性醛固酮增多症患者的该指标显著高于年龄匹配的血压正常者。切除腺瘤后,高血浆水平的哇巴因样免疫反应性降至正常。腺瘤组织提取物未含有任何明显的哇巴因样免疫反应性。本研究中使用的抗哇巴因抗体与醛固酮、皮质醇、皮质酮、花生四烯酸或溶血磷脂酰胆碱无交叉反应。术后高血压、低钾血症、高血浆醛固酮水平和低血浆肾素活性也恢复正常。这些结果表明,醛固酮增多症诱导血浆中高哇巴因样免疫反应性水平,这在一定程度上与原发性醛固酮增多症中的高血压相关。

相似文献

1
Normalization of high plasma level of ouabain-like immunoreactivity in primary aldosteronism after removal of adenoma.原发性醛固酮增多症患者腺瘤切除后血浆中哇巴因样免疫反应性高水平恢复正常。
J Hum Hypertens. 1988 Jun;2(1):17-20.
2
Plasma ouabain-like activity in essential hypertensive patients and in subjects with primary aldosteronism.原发性高血压患者及原发性醛固酮增多症患者的血浆哇巴因样活性。
Miner Electrolyte Metab. 1989;15(5):315-20.
3
Circulating factor with ouabain-like immunoreactivity in patients with primary aldosteronism.原发性醛固酮增多症患者中具有哇巴因样免疫反应性的循环因子。
Biochem Biophys Res Commun. 1986 Feb 26;135(1):41-5. doi: 10.1016/0006-291x(86)90939-3.
4
Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.原发性醛固酮增多症中钙代谢和甲状旁腺功能的改变,以及螺内酯或手术切除醛固酮分泌腺瘤对其的逆转作用。
Am J Hypertens. 1995 Sep;8(9):884-93. doi: 10.1016/0895-7061(95)00182-O.
5
Normokalemic hyperaldosteronism in patients with resistant hypertension.顽固性高血压患者的正常血钾性醛固酮增多症
Isr Med Assoc J. 2002 Jan;4(1):17-20.
6
Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.醛固酮瘤治疗后肾功能与残余高血压的关联
Am J Kidney Dis. 2009 Oct;54(4):665-73. doi: 10.1053/j.ajkd.2009.06.014. Epub 2009 Jul 23.
7
Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.原发性醛固酮增多症患者行肾上腺切除术的血压结局:有无单侧腺瘤的情况
J Hypertens. 2008 Sep;26(9):1816-23. doi: 10.1097/HJH.0b013e3283060f0c.
8
Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.原发性醛固酮增多症和原发性高血压中免疫反应性内源性哇巴因:与血浆肾素、醛固酮及血压水平的关系
J Hypertens. 1995 Oct;13(10):1181-91. doi: 10.1097/00004872-199510000-00013.
9
[High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].[原发性高血压患者中未诊断出的原发性醛固酮增多症的高患病率]
Rev Med Chil. 1999 Jul;127(7):800-6.
10
[Primary hyperaldosteronism--12 clinical cases].[原发性醛固酮增多症——12例临床病例]
Rev Port Cardiol. 1999 Sep;18(9):801-12.

引用本文的文献

1
Sensational site: the sodium pump ouabain-binding site and its ligands.激动人心的研究地点:钠泵哇巴因结合位点及其配体。
Am J Physiol Cell Physiol. 2024 Apr 1;326(4):C1120-C1177. doi: 10.1152/ajpcell.00273.2023. Epub 2024 Jan 15.
2
Much More than a Cardiotonic Steroid: Modulation of Inflammation by Ouabain.不仅仅是一种强心甾体:哇巴因对炎症的调节作用。
Front Physiol. 2017 Nov 10;8:895. doi: 10.3389/fphys.2017.00895. eCollection 2017.
3
Update on angiotensin II: new endocrine connections between the brain, adrenal glands and the cardiovascular system.
血管紧张素II的最新进展:大脑、肾上腺与心血管系统之间新的内分泌联系
Endocr Connect. 2017 Oct;6(7):R131-R145. doi: 10.1530/EC-17-0161. Epub 2017 Aug 30.
4
Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.哇巴因作为常染色体显性多囊肾病的囊原性因子的新作用。
Am J Physiol Renal Physiol. 2013 Sep 15;305(6):F797-812. doi: 10.1152/ajprenal.00248.2013. Epub 2013 Jun 12.
5
Nanomolar ouabain increases NCX1 expression and enhances Ca2+ signaling in human arterial myocytes: a mechanism that links salt to increased vascular resistance?纳米摩尔哇巴因增加人动脉平滑肌细胞的 NCX1 表达并增强 Ca2+信号转导:盐与血管阻力增加相关的一种机制?
Am J Physiol Heart Circ Physiol. 2012 Oct 1;303(7):H784-94. doi: 10.1152/ajpheart.00399.2012. Epub 2012 Jul 27.
6
How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.高盐如何导致血压升高:盐依赖性高血压发病机制的新范例。
Am J Physiol Heart Circ Physiol. 2012 Mar 1;302(5):H1031-49. doi: 10.1152/ajpheart.00899.2011. Epub 2011 Nov 4.
7
The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.高血压的中心机制:钠离子、上皮钠通道、肾素-血管紧张素-醛固酮系统、氧化应激和脑内内源性洋地黄素作用的综述。
Hypertens Res. 2011 Nov;34(11):1147-60. doi: 10.1038/hr.2011.105. Epub 2011 Aug 4.
8
Endogenous ouabain: a link between sodium intake and hypertension.内源性哇巴因:钠摄入量与高血压之间的联系。
Curr Hypertens Rep. 2011 Feb;13(1):14-20. doi: 10.1007/s11906-010-0161-z.
9
Endogenous ouabain in renal Na(+) handling and related diseases.内源性哇巴因在肾脏钠处理及相关疾病中的作用
Biochim Biophys Acta. 2010 Dec;1802(12):1214-8. doi: 10.1016/j.bbadis.2010.03.001. Epub 2010 Mar 11.
10
Insulin resistance and endogenous digoxin-like factor in obese hypertensive patients with glucose intolerance.
Acta Diabetol. 1992;28(3-4):203-5. doi: 10.1007/BF00778999.